OY LX THERAPIES
Lx Therapies, founded in 2008, is a drug discovery company focused on developing genemediated therapies for the prevention and treatment of diseases of lymphatic vasculature. The initial focus of the company is on breast cancer-related lymphoedema, a relatively common complication of breast cancer treatment for which there is currently no cure or effective treatment. Lx Therapies, based in Helsinki, has received a EUR 2 million investment from Inveni Capital, the Finnish-German life sciences venture fund and a founder of Lx Therapies.
OY LX THERAPIES
Industry:
Biotechnology Health Care Therapeutics
Founded:
2008-01-01
Address:
Helsinki, Southern Finland, Finland
Country:
Finland
Status:
Active
Total Funding:
2.63 M USD
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Delenex Therapeutics
Delenex Therapeutics is engaged in developing therapeutic antibody fragments for diseases with high unmet needs.
Médipole Garonne
Médipole Garonne Clinic, focused on orthopedic surgery and care of the athlete, has reached its phase of maturity.
Investors List
Inveni Capital
Inveni Capital investment in Venture Round - OY LX Therapies